Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds BTIG Downgrades OncoSec Medical to Neutral

BTIG Downgrades OncoSec Medical to Neutral

BTIG analyst Kaveri Pohlman downgrades OncoSec Medical (NASDAQ:ONCS) from Buy to Neutral.

byBenzinga Newsdesk

November 14, 2022

1 minute read

BTIG analyst Kaveri Pohlman downgrades OncoSec Medical (NASDAQ:ONCS) from Buy to Neutral.

Analyst Ratings

Near-Term Headwinds Present An Opportunity In Ross Stores

By MarketBeat

August 19, 11:36 AM

If you are looking for a bargain in the Retail Sector Ross Stores (NASDAQ: ROST) is not it but it is a relatively safe dividend payer that also buys back shares.

ROST

Midland States Bancorp Prices $115M Offering of Depositary Shares

By Michael Horton

Today, 5:53 PM

Midland States Bancorp, Inc. ("Midland" or the "Company") (NASDAQ:MSBI), the holding company for Midland States Bank (the "Bank"), announced today that it has priced an underwritten public

MSBI

Recap: New Residential Inv Q2 Earnings

By Benzinga Insights

August 2, 9:30 AM

New Residential Inv (NYSE:NRZ) reported its Q2 earnings results on Tuesday, August 2, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Earnings New Residential Inv reported in-line EPS of $0.31 versus an estimate of $0.31.

NRZ